Li Li

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Yongkun Sun, Wei Niu, Feng Du et al. · Journal of Hematology & Oncology · 2016 · 431 citations · Full text

Medicine, Oncology, Pharmacology +15

Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use

Robert L. Ferris, Lisa Licitra, Jérôme Fayette et al. · Clinical Cancer Research · 2019 · 160 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline

Ling Zhou, Juan Zhang, Xiaomin Jiang et al. · JACC: Cardiovascular Interventions · 2015 · 85 citations

Medicine, Cardiology, Pulmonology +7

Cordycepin Inhibits Renal Interstitial Myofibroblast Activation Probably by Inducing Hepatocyte Growth Factor Expression

Li Li, Dongyuan He, Junwei Yang et al. · Journal of Pharmacological Sciences · 2011 · 32 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

CRH suppressed TGFβ1-induced Epithelial–Mesenchymal Transition via induction of E-cadherin in breast cancer cells

Lai Jin, Jiandong Chen, Li Li et al. · Cellular Signalling · 2014 · 23 citations

Life Sciences, Cell Biology, Molecular Biology +14